Perceptive Xontogeny Ventures

Perceptive Xontogeny Ventures is the venture capital strategy of Perceptive Advisors, based in New York and investing in U.S. early-stage life sciences companies. It focuses on seed and Series A financings, can lead or co-lead investments, and typically invests $10 million to $50 million. The strategy targets biotechnology, medical devices, healthtech, digital health, healthcare tools and services, and differentiated technologies aimed at therapeutic impact or healthcare delivery improvements.